A CU Medicine provider.
My approach to care centers on building a true partnership with each patient and family, grounded in clear and direct communication, compassion, and respect for individual goals and values. As a medical oncologist specializing in genitourinary cancers, I aim to provide evidence-based, personalized treatment while helping patients navigate complex decisions with confidence. I am deeply committed to advancing the field through clinical trials and translational research, with a focus on innovative therapies and understanding why treatments work for some patients and not others. By integrating cutting-edge science with attentive, whole-person care, I strive to offer patients access to the most promising options today while contributing to better treatments for the future. I am seeing patients with prostate cancer, testicular (germ cell) cancer, adrenal cortical cancer, bladder/urothelial cancer, kidney cancer, and rare genitourinary cancers.
Locations
720.848.0170
720.848.0180Qualifications and experience
- Specialties
- Medical Oncology, Internal Medicine, Cancers, Cancers - Kidney Cancer, Cancers - Prostate Cancer, Cancers - Testicular Cancer, Cancers - Urologic Cancer, Cancers - Bladder Cancer
- Gender
- Female
- Languages spoken
- Education
-
Fellowship
University of Washington Program (2021)
Medical School
Rush Medical College of Rush University Medical Center (2015)
Residency
University of Washington Program (2018)
Undergraduate
University of Chicago (IL) (2009)
- Research interest for patients
-
My research focuses on developing more effective treatments for advanced prostate cancer and other genitourinary malignancies through innovative clinical trials and translational science. I am particularly interested in hormone-based therapies, immunotherapy combinations, and T-cell–directed approaches aimed at overcoming treatment resistance and improving durable responses. My work integrates patient care with laboratory investigation, including analyses of blood and tumor samples to better understand how therapies reshape the tumor immune microenvironment and to identify biomarkers that predict which patients are most likely to benefit. I collaborate closely with multidisciplinary academic teams, cooperative groups, and industry partners to accelerate the development of personalized therapies and to translate promising scientific discoveries into meaningful advances for patients with genitourinary cancers.
- Insurance
- UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.